APP and Alzheimer disease: In the transgenic APP/PS1 (APPswe/PS1dE9) mouse model for Alzheimer’s disease, depletion of microglia using a Csf1r inhibitor (PLX5622) results in an increase in parenchymal T cell numbers and a reduction of anti-inflammatory cytokines [88].